Julie Anja Engelhard Christensen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Julie Anja Engelhard Christensen has a total of 106 co-authors. Here are the top co-authors by number of shared publications:
Poul Jennum
Danish Center for Sleep Medicine, Department of Clinical Neurophysiology , Rigshospitalet Glostrup , Denmark
30 shared publications- Helge Bjarrup Dissing Sorensen
Department of Health Technology, Technical University of Denmark, Kgs. Lyngby, Denmark
24 shared publications - Matteo Cesari
Department of Neurology, Medical University of Innsbruck , Innsbruck
10 shared publications Jacob Kempfner
Department of Electrical Engineering, Technical University of Denmark, Kongens Lyngby, Denmark; Danish Center for Sleep Medicine University of Copenhagen, Glostrup Hospital, Glostrup, Denmark
7 shared publicationsLars Arvastson
H. Lundbeck A/S, Copenhagen, Denmark
7 shared publications- Alexander Neergaard Olesen
Department of Applied Mathematics and Computer Science, Technical University of Denmark , Kgs. Lyngby
6 shared publications
Latest Publications
- Open Access
- 28 January 2026
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 49 (5)
High-resolution sleep fragmentation assessment in narcolepsy type 1 and their non-narcoleptic siblings: a 5-s mini-epoch study
Study Objectives: Narcolepsy type 1 (NT1) is characterized by fragmented sleep, yet brief transitions may be concealed in traditional 30-s epochs. We therefore aimed to assess sleep fragmentation in NT1 patients and their non-narcoleptic siblings using 5-s mini-epochs. Methods: We analyzed sleep stages from human-scored 30-s epochs and automatically (U-Sleep) scored 5-s mini-epochs in polysomnographies from 125 NT1 patients and their 100 non-narcoleptic siblings. Sleep fragmentation was quantified using transition indices and probabilities in epochs and mini-epochs, furthermore, stratified by 1st and 2nd night-half. Predictors (H1N1-vaccination, CSF hypocretin-1 deficiency severity (low [40–150 pg/mL]; undetectable [<40 pg/mL]), HLA-DQB1*06:02-positivity, narcolepsy core symptom severity) for sleep transitions were explored. Results: NT1 patients had significantly higher all-stages and sleep–wake transition indices compared to siblings in epochs and mini-epochs. Both epoch and mini-epoch transition indices varied significantly from 1st to 2nd night-half. Only in mini-epochs, sleep–wake fragmentation was (a) higher in patients with severe core symptoms, and (b) increased in the 2nd night-half in NT1 patients with severe hypocretin-1 deficiency (<40 pg/mL) and/or severe core symptoms. Conclusions: Our findings suggest that sleep fragmentation, a core feature of NT1, is associated with disease severity and hypocretin deficiency severity when high-resolution sleep stages are analyzed. Five-second sleep staging and split-night analyses enhance detection of sleep instability and reveal new specific patterns and clinical associations. Automated mini-epoch analyses may improve future NT1 phenotyping and possibly its borderland by supplementing with clinically relevant high-resolution features otherwise hidden in traditional full-night 30-s epoch analyses. Statement of Significance This study demonstrates that high-resolution 5-s sleep staging provides more detailed sleep characterization than epochs and additionally uncovers clinically relevant sleep fragmentation patterns in narcolepsy type 1 which remain hidden in traditional 30-s analyses. By combining 5-s mini-epoch scoring with split-night analyses, we identified specific associations between disease severity and increased sleep–wake fragmentation. In mini-epochs, but not in epochs, sleep–wake fragmentation was significantly higher in patients with all core narcolepsy symptoms and increased significantly from the 1st to the 2nd night-half in patients with undetectable hypocretin-1 levels (<40 pg/mL) and/or all core narcolepsy symptoms. These findings highlight the clinical value of high-resolution, temporally sensitive sleep stage analyses for detailed phenotyping and detection of future disease biomarkers.
- 28 January 2026
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 49 (5)
Open AccessHigh-resolution sleep fragmentation assessment in narcolepsy type 1 and their non-narcoleptic siblings: a 5-s mini-epoch study
Study Objectives: Narcolepsy type 1 (NT1) is characterized by fragmented sleep, yet brief transitions may be concealed in traditional 30-s epochs. We therefore aimed to assess sleep fragmentation in NT1 patients and their non-narcoleptic siblings using 5-s mini-epochs. Methods: We analyzed sleep stages from human-scored 30-s epochs and automatically (U-Sleep) scored 5-s mini-epochs in polysomnographies from 125 NT1 patients and their 100 non-narcoleptic siblings. Sleep fragmentation was quantified using transition indices and probabilities in epochs and mini-epochs, furthermore, stratified by 1st and 2nd night-half. Predictors (H1N1-vaccination, CSF hypocretin-1 deficiency severity (low [40–150 pg/mL]; undetectable [<40 pg/mL]), HLA-DQB1*06:02-positivity, narcolepsy core symptom severity) for sleep transitions were explored. Results: NT1 patients had significantly higher all-stages and sleep–wake transition indices compared to siblings in epochs and mini-epochs. Both epoch and mini-epoch transition indices varied significantly from 1st to 2nd night-half. Only in mini-epochs, sleep–wake fragmentation was (a) higher in patients with severe core symptoms, and (b) increased in the 2nd night-half in NT1 patients with severe hypocretin-1 deficiency (<40 pg/mL) and/or severe core symptoms. Conclusions: Our findings suggest that sleep fragmentation, a core feature of NT1, is associated with disease severity and hypocretin deficiency severity when high-resolution sleep stages are analyzed. Five-second sleep staging and split-night analyses enhance detection of sleep instability and reveal new specific patterns and clinical associations. Automated mini-epoch analyses may improve future NT1 phenotyping and possibly its borderland by supplementing with clinically relevant high-resolution features otherwise hidden in traditional full-night 30-s epoch analyses. Statement of Significance This study demonstrates that high-resolution 5-s sleep staging provides more detailed sleep characterization than epochs and additionally uncovers clinically relevant sleep fragmentation patterns in narcolepsy type 1 which remain hidden in traditional 30-s analyses. By combining 5-s mini-epoch scoring with split-night analyses, we identified specific associations between disease severity and increased sleep–wake fragmentation. In mini-epochs, but not in epochs, sleep–wake fragmentation was significantly higher in patients with all core narcolepsy symptoms and increased significantly from the 1st to the 2nd night-half in patients with undetectable hypocretin-1 levels (<40 pg/mL) and/or all core narcolepsy symptoms. These findings highlight the clinical value of high-resolution, temporally sensitive sleep stage analyses for detailed phenotyping and detection of future disease biomarkers.
- Open Access
- 12 December 2025
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 49 (4)
Optimizing automated sleep stage scoring of 5-s mini-epochs: a transfer learning study
Study Objectives: Conventional sleep staging relies on 30-s epochs, potentially concealing transient sleep stage intrusion and reducing precision. Building on our previous study of mini-epochs, we investigated whether U-Sleep, an existing automatic deep learning-based sleep staging model with high performance in epochs, could be optimized to similar performance level in 5-s mini-epoch scoring, thereby enabling more detailed sleep characterization. Methods: We created a dataset of 48 000 human-scored 5-s mini-epochs from 100 polysomnographies. We compared mini-epochs to human-scored epochs before U-Sleep was optimized using transfer learning and evaluated on a test set. Model performance was assessed using F1-scores, confusion matrices, stage distributions and transition rates comparing scorings of the original U-Sleep before, and the optimized U-Sleep after transfer learning to human-scored mini-epochs. Results: Compared to human-scored epochs, human-scored mini-epochs captured significantly more transitions (1.70/min vs. 0.21/min, p < .001), and significantly more wake (8.4 per cent vs. 5.4 per cent), N1 (7.2 per cent vs. 5.4 per cent), and N2 (51.8 per cent vs. 40.9 per cent), less N3 (15.4 per cent vs. 25.2 per cent), and REM sleep (16.7 per cent vs. 23.0 per cent) (all p < .001). Optimizing U-Sleep improved its performance significantly from F1 = 0.74 to F1 = 0.81 (p < .05) and gave increased transition rates in the test set (original U-Sleep: 1.06/min, optimized U-Sleep: 1.34/min, human-scored mini-epochs: 1.70/min). Stage distributions did not differ between optimized U-Sleep’s scorings and human-scored mini-epochs. Conclusion: After optimization, U-Sleep performance in mini-epochs matched the high performance levels previously reported in both human and automated 30-s epoch scoring. This demonstrates the feasibility of precise, automated high-resolution sleep staging. Future work should include external validation and application to full-night recordings. Statement of Significance Conventional 30-s epochs limit temporal resolution in sleep staging and may conceal transient intrusions of wake or sleep stages. However, no validated methods are available for high-resolution scoring. In this study, we trained and validated the state-of-the-art deep learning model U-Sleep for accurate automatic 5-s mini-epoch scoring using a large dataset of human-scored mini-epochs. The optimized model achieved a high performance, matching levels from previously reported automatic and human epoch scoring. Compared to epoch scoring, mini-epochs captured significantly more stage transitions, supporting their ability to uncover sleep dynamics that are otherwise lost. Our findings show the potential of high-resolution sleep staging for more detailed characterization of sleep architecture and demonstrate the feasibility of precise, automatic mini-epoch scoring.
- 12 December 2025
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 49 (4)
Open AccessOptimizing automated sleep stage scoring of 5-s mini-epochs: a transfer learning study
Study Objectives: Conventional sleep staging relies on 30-s epochs, potentially concealing transient sleep stage intrusion and reducing precision. Building on our previous study of mini-epochs, we investigated whether U-Sleep, an existing automatic deep learning-based sleep staging model with high performance in epochs, could be optimized to similar performance level in 5-s mini-epoch scoring, thereby enabling more detailed sleep characterization. Methods: We created a dataset of 48 000 human-scored 5-s mini-epochs from 100 polysomnographies. We compared mini-epochs to human-scored epochs before U-Sleep was optimized using transfer learning and evaluated on a test set. Model performance was assessed using F1-scores, confusion matrices, stage distributions and transition rates comparing scorings of the original U-Sleep before, and the optimized U-Sleep after transfer learning to human-scored mini-epochs. Results: Compared to human-scored epochs, human-scored mini-epochs captured significantly more transitions (1.70/min vs. 0.21/min, p < .001), and significantly more wake (8.4 per cent vs. 5.4 per cent), N1 (7.2 per cent vs. 5.4 per cent), and N2 (51.8 per cent vs. 40.9 per cent), less N3 (15.4 per cent vs. 25.2 per cent), and REM sleep (16.7 per cent vs. 23.0 per cent) (all p < .001). Optimizing U-Sleep improved its performance significantly from F1 = 0.74 to F1 = 0.81 (p < .05) and gave increased transition rates in the test set (original U-Sleep: 1.06/min, optimized U-Sleep: 1.34/min, human-scored mini-epochs: 1.70/min). Stage distributions did not differ between optimized U-Sleep’s scorings and human-scored mini-epochs. Conclusion: After optimization, U-Sleep performance in mini-epochs matched the high performance levels previously reported in both human and automated 30-s epoch scoring. This demonstrates the feasibility of precise, automated high-resolution sleep staging. Future work should include external validation and application to full-night recordings. Statement of Significance Conventional 30-s epochs limit temporal resolution in sleep staging and may conceal transient intrusions of wake or sleep stages. However, no validated methods are available for high-resolution scoring. In this study, we trained and validated the state-of-the-art deep learning model U-Sleep for accurate automatic 5-s mini-epoch scoring using a large dataset of human-scored mini-epochs. The optimized model achieved a high performance, matching levels from previously reported automatic and human epoch scoring. Compared to epoch scoring, mini-epochs captured significantly more stage transitions, supporting their ability to uncover sleep dynamics that are otherwise lost. Our findings show the potential of high-resolution sleep staging for more detailed characterization of sleep architecture and demonstrate the feasibility of precise, automatic mini-epoch scoring.
- Open Access
Optimizing automated sleep stage scoring of 5-second mini-epochs: a transfer learning study
Study objective: Conventional sleep staging relies on 30-second epochs, potentially concealing transient sleep stage intrusion and reducing precision. Building on our previous study of mini-epochs, we investigated whether U-Sleep, an existing automatic deep learning-based sleep staging model with high performance in epochs, could be optimized to similar performance level in 5-second mini-epoch scoring, thereby enabling more detailed sleep characterization. Methods: We created a dataset of 48,000 human-scored 5-second mini-epochs from 100 PSGs. We compared mini-epochs to human-scored epochs before U-Sleep was optimized using transfer learning and evaluated on a test set. Model performance was assessed using F1-scores, confusion matrices, stage distributions and transition rates comparing scorings of the original U-Sleep before, and the optimized U-Sleep after transfer learning to human-scored mini-epochs. Results: Compared to human-scored epochs, human-scored mini-epochs captured significantly more transitions (1.70/minute vs. 0.21/minute, p<0.001), and significantly more wake (8.4% versus 5.4%), N1 (7.2% versus 5.4%), and N2 (51.8% versus 40.9%), less N3 (15.4% versus 25.2%) and REM sleep (16.7% versus 23.0%) (all p<0.001). Optimizing U-Sleep improved its performance significantly from F1=0.74 to F1=0.81 (p<0.05) and gave increased transition rates in the test set (original U-Sleep: 1.06/minute, optimized U-Sleep: 1.34/minute, human-scored miniepochs: 1.70/minute). Stage distributions did not differ between optimized U-Sleep’s scorings and human-scored mini-epochs. Conclusions: After optimization, U-Sleep performance in mini-epochs matched the high performance levels previously reported in both human and automated 30-second epoch scoring. This demonstrates the feasibility of precise, automated high resolution sleep staging. Future work should include external validation and application to full-night recordings. Statement of significance: Conventional 30-second epochs limit temporal resolution in sleep staging and may conceal transient intrusions of wake or sleep stages. However, no validated methods are available for highresolution scoring. In this study, we trained and validated the state-of-the-art deep learning model U-Sleep for accurate automatic 5-second mini-epoch scoring using a large dataset of humanscored mini-epochs. The optimized model achieved a high performance, matching levels from previously reported automatic and human epoch scoring. Compared to epoch scoring, miniepochs captured significantly more stage transitions, supporting their ability to uncover sleep dynamics that are otherwise lost. Our findings show the potential of high-resolution sleep staging for more detailed characterization of sleep architecture and demonstrate the feasibility of precise, automatic mini-epoch scoring.
Open AccessOptimizing automated sleep stage scoring of 5-second mini-epochs: a transfer learning study
Study objective: Conventional sleep staging relies on 30-second epochs, potentially concealing transient sleep stage intrusion and reducing precision. Building on our previous study of mini-epochs, we investigated whether U-Sleep, an existing automatic deep learning-based sleep staging model with high performance in epochs, could be optimized to similar performance level in 5-second mini-epoch scoring, thereby enabling more detailed sleep characterization. Methods: We created a dataset of 48,000 human-scored 5-second mini-epochs from 100 PSGs. We compared mini-epochs to human-scored epochs before U-Sleep was optimized using transfer learning and evaluated on a test set. Model performance was assessed using F1-scores, confusion matrices, stage distributions and transition rates comparing scorings of the original U-Sleep before, and the optimized U-Sleep after transfer learning to human-scored mini-epochs. Results: Compared to human-scored epochs, human-scored mini-epochs captured significantly more transitions (1.70/minute vs. 0.21/minute, p<0.001), and significantly more wake (8.4% versus 5.4%), N1 (7.2% versus 5.4%), and N2 (51.8% versus 40.9%), less N3 (15.4% versus 25.2%) and REM sleep (16.7% versus 23.0%) (all p<0.001). Optimizing U-Sleep improved its performance significantly from F1=0.74 to F1=0.81 (p<0.05) and gave increased transition rates in the test set (original U-Sleep: 1.06/minute, optimized U-Sleep: 1.34/minute, human-scored miniepochs: 1.70/minute). Stage distributions did not differ between optimized U-Sleep’s scorings and human-scored mini-epochs. Conclusions: After optimization, U-Sleep performance in mini-epochs matched the high performance levels previously reported in both human and automated 30-second epoch scoring. This demonstrates the feasibility of precise, automated high resolution sleep staging. Future work should include external validation and application to full-night recordings. Statement of significance: Conventional 30-second epochs limit temporal resolution in sleep staging and may conceal transient intrusions of wake or sleep stages. However, no validated methods are available for highresolution scoring. In this study, we trained and validated the state-of-the-art deep learning model U-Sleep for accurate automatic 5-second mini-epoch scoring using a large dataset of humanscored mini-epochs. The optimized model achieved a high performance, matching levels from previously reported automatic and human epoch scoring. Compared to epoch scoring, miniepochs captured significantly more stage transitions, supporting their ability to uncover sleep dynamics that are otherwise lost. Our findings show the potential of high-resolution sleep staging for more detailed characterization of sleep architecture and demonstrate the feasibility of precise, automatic mini-epoch scoring.
- Top Cited Papers
- 25 October 2021
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 45 (3)
Video-polysomnography procedures for diagnosis of rapid eye movement sleep behavior disorder (RBD) and the identification of its prodromal stages: guidelines from the International RBD Study Group
Video-polysomnography (v-PSG) is essential for diagnosing rapid eye movement (REM) sleep behavior disorder (RBD). Although there are current American Academy of Sleep Medicine standards to diagnose RBD, several aspects need to be addressed to achieve harmonization across sleep centers. Prodromal RBD is a stage in which symptoms and signs of evolving RBD are present, but do not yet meet established diagnostic criteria for RBD. However, the boundary between prodromal and definite RBD is still unclear. As a common effort of the Neurophysiology Working Group of the International RBD Study Group, this manuscript addresses the need for comprehensive and unambiguous v-PSG recommendations to diagnose RBD and identify prodromal RBD. These include: (1) standardized v-PSG technical settings; (2) specific considerations for REM sleep scoring; (3) harmonized methods for scoring REM sleep without atonia; (4) consistent methods to analyze video and audio recorded during v-PSGs and to classify movements and vocalizations; (5) clear v-PSG guidelines to diagnose RBD and identify prodromal RBD. Each section follows a common template: The current recommendations and methods are presented, their limitations are outlined, and new recommendations are described. Finally, future directions are presented. These v-PSG recommendations are intended for both practicing clinicians and researchers. Classification and quantification of motor events, RBD episodes, and vocalizations are however intended for research purposes only. These v-PSG guidelines will allow collection of homogeneous data, providing objective v-PSG measures and making future harmonized multicentric studies and clinical trials possible.
- 25 October 2021
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 45 (3)
Top Cited PapersVideo-polysomnography procedures for diagnosis of rapid eye movement sleep behavior disorder (RBD) and the identification of its prodromal stages: guidelines from the International RBD Study Group
Video-polysomnography (v-PSG) is essential for diagnosing rapid eye movement (REM) sleep behavior disorder (RBD). Although there are current American Academy of Sleep Medicine standards to diagnose RBD, several aspects need to be addressed to achieve harmonization across sleep centers. Prodromal RBD is a stage in which symptoms and signs of evolving RBD are present, but do not yet meet established diagnostic criteria for RBD. However, the boundary between prodromal and definite RBD is still unclear. As a common effort of the Neurophysiology Working Group of the International RBD Study Group, this manuscript addresses the need for comprehensive and unambiguous v-PSG recommendations to diagnose RBD and identify prodromal RBD. These include: (1) standardized v-PSG technical settings; (2) specific considerations for REM sleep scoring; (3) harmonized methods for scoring REM sleep without atonia; (4) consistent methods to analyze video and audio recorded during v-PSGs and to classify movements and vocalizations; (5) clear v-PSG guidelines to diagnose RBD and identify prodromal RBD. Each section follows a common template: The current recommendations and methods are presented, their limitations are outlined, and new recommendations are described. Finally, future directions are presented. These v-PSG recommendations are intended for both practicing clinicians and researchers. Classification and quantification of motor events, RBD episodes, and vocalizations are however intended for research purposes only. These v-PSG guidelines will allow collection of homogeneous data, providing objective v-PSG measures and making future harmonized multicentric studies and clinical trials possible.
- 1 April 2021
- Published by Elsevier in Journal of Psychiatric Research
- Vol. 136, 198-203
Association of neurocognitive functioning with sleep stage dissociation and REM sleep instability in medicated patients with schizophrenia
- 1 April 2021
- Published by Elsevier in Journal of Psychiatric Research
- Vol. 136, 198-203
Association of neurocognitive functioning with sleep stage dissociation and REM sleep instability in medicated patients with schizophrenia
- 29 November 2020
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 44 (5)
Cortical arousal frequency is increased in narcolepsy type 1
Hypocretin deficient narcolepsy (type 1, NT1) presents with multiple sleep abnormalities including sleep onset rapid eye movement (REM) periods (SOREMPs) and sleep fragmentation. We hypothesized that cortical arousals, as scored by an automatic detector, are elevated in NT1 and narcolepsy type 2 (NT2) patients as compared to control subjects. We analyzed nocturnal polysomnography (PSG) recordings from 25 NT1 patients, 20 NT2 patients, 18 clinical control subjects (CC, suspected central hypersomnia but with normal cerebrospinal (CSF) fluid hypocretin-1 (hcrt-1) levels and normal results on the multiple sleep latency test), and 37 healthy control (HC) subjects. Arousals were automatically scored using Multimodal Arousal Detector (MAD), a previously validated automatic wakefulness and arousal detector. Multiple linear regressions were used to compare arousal index (ArI) distributions across groups. Comparisons were corrected for age, sex, body-mass index, medication, apnea-hypopnea index, periodic leg movement index, and comorbid rapid eye movement sleep behavior disorder. NT1 was associated with an average increase in ArI of 4.02 events/hour (p = 0.0246) compared to HC and CC, while no difference was found between NT2 and control groups. Additionally, a low CSF hcrt-1 level was predictive of increased ArI in all the CC, NT2, and NT1 groups. The results further support the hypothesis that a loss of hypocretin neurons causes fragmented sleep, which can be measured as an increased ArI as scored by the MAD.
- 29 November 2020
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 44 (5)
Cortical arousal frequency is increased in narcolepsy type 1
Hypocretin deficient narcolepsy (type 1, NT1) presents with multiple sleep abnormalities including sleep onset rapid eye movement (REM) periods (SOREMPs) and sleep fragmentation. We hypothesized that cortical arousals, as scored by an automatic detector, are elevated in NT1 and narcolepsy type 2 (NT2) patients as compared to control subjects. We analyzed nocturnal polysomnography (PSG) recordings from 25 NT1 patients, 20 NT2 patients, 18 clinical control subjects (CC, suspected central hypersomnia but with normal cerebrospinal (CSF) fluid hypocretin-1 (hcrt-1) levels and normal results on the multiple sleep latency test), and 37 healthy control (HC) subjects. Arousals were automatically scored using Multimodal Arousal Detector (MAD), a previously validated automatic wakefulness and arousal detector. Multiple linear regressions were used to compare arousal index (ArI) distributions across groups. Comparisons were corrected for age, sex, body-mass index, medication, apnea-hypopnea index, periodic leg movement index, and comorbid rapid eye movement sleep behavior disorder. NT1 was associated with an average increase in ArI of 4.02 events/hour (p = 0.0246) compared to HC and CC, while no difference was found between NT2 and control groups. Additionally, a low CSF hcrt-1 level was predictive of increased ArI in all the CC, NT2, and NT1 groups. The results further support the hypothesis that a loss of hypocretin neurons causes fragmented sleep, which can be measured as an increased ArI as scored by the MAD.
- 28 August 2020
- Published by Wiley in Journal of Sleep Research
- Vol. 30 (3) , e13125
Nocturnal eye movements in patients with idiopathic rapid eye movement sleep behaviour disorder and patients with Parkinson’s disease
Patients with idiopathic rapid‐eye‐movement (REM) sleep behaviour disorder (iRBD) have a high risk of converting into manifest α‐synucleinopathies. Eye movements (EMs) are controlled by neurons in the lower brainstem, midbrain and frontal areas, and may be affected by the early neurodegenerative process seen in iRBD. Studies have reported impairment of the oculomotor function in patients with Parkinson's disease (PD) during wakefulness, but no studies have investigated EMs during sleep. We aimed to evaluate nocturnal EMs in iRBD and PD, hypothesizing that these patients present abnormal EM distribution during sleep. Twenty‐eight patients with periodic limb movement disorder (PLMD), 24 iRBD, 23 PD without RBD (PDwoRBD), 29 PD and RBD (PDwRBD) and 24 controls were included. A validated EM detector automatically identified EM periods between lights off and on. The EM coverage was computed as the percentage of time containing EMs during stable wake after lights off, N1, N2, N3 and REM sleep. Between‐group comparisons revealed that PDwRBD had significantly less EM coverage during wake and significantly higher EM coverage during N2 compared to controls and PLMD patients. PDwoRBD showed significantly less EM coverage during wake compared to controls and higher EM coverage during N2 compared to controls and PLMD. Finally, iRBD showed less coverage of EM during wake compared to controls. The same trend was observed between iRBD and controls in N2 but was not significant. The different profiles of EM coverage in iRBD and PD with/without RBD may mirror different stages of central nervous system involvement across neurodegenerative disease progression.
- 28 August 2020
- Published by Wiley in Journal of Sleep Research
- Vol. 30 (3) , e13125
Nocturnal eye movements in patients with idiopathic rapid eye movement sleep behaviour disorder and patients with Parkinson’s disease
Patients with idiopathic rapid‐eye‐movement (REM) sleep behaviour disorder (iRBD) have a high risk of converting into manifest α‐synucleinopathies. Eye movements (EMs) are controlled by neurons in the lower brainstem, midbrain and frontal areas, and may be affected by the early neurodegenerative process seen in iRBD. Studies have reported impairment of the oculomotor function in patients with Parkinson's disease (PD) during wakefulness, but no studies have investigated EMs during sleep. We aimed to evaluate nocturnal EMs in iRBD and PD, hypothesizing that these patients present abnormal EM distribution during sleep. Twenty‐eight patients with periodic limb movement disorder (PLMD), 24 iRBD, 23 PD without RBD (PDwoRBD), 29 PD and RBD (PDwRBD) and 24 controls were included. A validated EM detector automatically identified EM periods between lights off and on. The EM coverage was computed as the percentage of time containing EMs during stable wake after lights off, N1, N2, N3 and REM sleep. Between‐group comparisons revealed that PDwRBD had significantly less EM coverage during wake and significantly higher EM coverage during N2 compared to controls and PLMD patients. PDwoRBD showed significantly less EM coverage during wake compared to controls and higher EM coverage during N2 compared to controls and PLMD. Finally, iRBD showed less coverage of EM during wake compared to controls. The same trend was observed between iRBD and controls in N2 but was not significant. The different profiles of EM coverage in iRBD and PD with/without RBD may mirror different stages of central nervous system involvement across neurodegenerative disease progression.
- 1 December 2019
- Published by Elsevier in Sleep Medicine
- Vol. 64, S59-S60
REM Sleep behavior disorder in Parkinson's disease: a model for identification and prediction of its progression from the prodromal stage
- 1 December 2019
- Published by Elsevier in Sleep Medicine
- Vol. 64, S59-S60
REM Sleep behavior disorder in Parkinson's disease: a model for identification and prediction of its progression from the prodromal stage
- Open Access
- 9 July 2019
- Published by Frontiers Media SA in Frontiers in Neuroscience
- Vol. 13, 598
Data-Driven Analysis of EEG Reveals Concomitant Superficial Sleep During Deep Sleep in Insomnia Disorder
Study Objectives: The subjective suffering of people with Insomnia Disorder (ID) is insufficiently accounted for by traditional sleep classification, which presumes a strict sequential occurrence of global brain states. Recent studies challenged this presumption by showing concurrent sleep- and wake-type neuronal activity. We hypothesized enhanced co-occurrence of diverging EEG vigilance signatures during sleep in ID. Methods: Electroencephalography (EEG) in 55 cases with ID and 64 controls without sleep complaints was subjected to a Latent Dirichlet Allocation topic model describing each 30 s epoch as a mixture of six vigilance states called Topics (T), ranked from N3-related T1 and T2 to wakefulness-related T6. For each stable epoch we determined topic dominance (the probability of the most likely topic), topic co-occurrence (the probability of the remaining topics), and epoch-to-epoch transition probabilities. Results: In stable epochs where the N1-related T4 was dominant, T4 was more dominant in ID than in controls, and patients showed an almost doubled co-occurrence of T4 during epochs where the N3-related T1 was dominant. Furthermore, patients had a higher probability of switching from T1- to T4-dominated epochs, at the cost of switching to N3-related T2-dominated epochs, and a higher probability of switching from N2-related T3- to wakefulness-related T6-dominated epochs. Conclusion: Even during their deepest sleep, the EEG of people with ID express more N1-related vigilance signatures than good sleepers do. People with ID are moreover more likely to switch from deep to light sleep and from N2 sleep to wakefulness. The findings suggest that hyperarousal never rests in ID.
- 9 July 2019
- Published by Frontiers Media SA in Frontiers in Neuroscience
- Vol. 13, 598
Open AccessData-Driven Analysis of EEG Reveals Concomitant Superficial Sleep During Deep Sleep in Insomnia Disorder
Study Objectives: The subjective suffering of people with Insomnia Disorder (ID) is insufficiently accounted for by traditional sleep classification, which presumes a strict sequential occurrence of global brain states. Recent studies challenged this presumption by showing concurrent sleep- and wake-type neuronal activity. We hypothesized enhanced co-occurrence of diverging EEG vigilance signatures during sleep in ID. Methods: Electroencephalography (EEG) in 55 cases with ID and 64 controls without sleep complaints was subjected to a Latent Dirichlet Allocation topic model describing each 30 s epoch as a mixture of six vigilance states called Topics (T), ranked from N3-related T1 and T2 to wakefulness-related T6. For each stable epoch we determined topic dominance (the probability of the most likely topic), topic co-occurrence (the probability of the remaining topics), and epoch-to-epoch transition probabilities. Results: In stable epochs where the N1-related T4 was dominant, T4 was more dominant in ID than in controls, and patients showed an almost doubled co-occurrence of T4 during epochs where the N3-related T1 was dominant. Furthermore, patients had a higher probability of switching from T1- to T4-dominated epochs, at the cost of switching to N3-related T2-dominated epochs, and a higher probability of switching from N2-related T3- to wakefulness-related T6-dominated epochs. Conclusion: Even during their deepest sleep, the EEG of people with ID express more N1-related vigilance signatures than good sleepers do. People with ID are moreover more likely to switch from deep to light sleep and from N2 sleep to wakefulness. The findings suggest that hyperarousal never rests in ID.
- 1 July 2019
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- Vol. 2019, 3649-3652
A Clinically Applicable Interactive Micro and Macro-Sleep Staging Algorithm for Elderly and Patients with Neurodegeneration
Elderly and patients with neurodegenerative diseases (NDD) often complain about sleep problems and show altered sleep structure. Automated algorithms for efficient and specific sleep staging are needed. We propose a new algorithm using only one electroencephalographic and two electrooculographic channels to score wakefulness, rapid eye movement (REM) sleep and non-REM sleep in a cohort of elderly healthy controls (HC), patients with Parkinson’s disease (PD), isolated REM sleep behavior disorder (iRBD), considered the prodromal stage of PD, and patients with PD and RBD (PD+RBD). The proposed method scores both standard 30-s epochs (macro-staging) and 5-s mini-epochs (micro-staging), whose evaluation may help to better understand sleep micro-structure. Moreover, the algorithm is interactive, as it labels the classified sleep epochs as either certain or uncertain, so that experts can manually review the uncertain ones. The algorithm performances were evaluated for macro-sleep staging, where it achieved overall accuracies of 0.87±0.05 in 41 HC, 0.86±0.10 in 57 PD, 0.76±0.10 in 31 iRBD and 0.77±0.10 in 30 PD+RBD patients when all 30-s epochs were considered. The accuracies increased to 0.91±0.05, 0.90±0.08, 0.85±0.09, 0.88±0.08 respectively when considering only the certain ones. The epochs labeled as uncertain were 9.95±4.15%, 11.13±7.86%, 18.39±7.38% and 18.90±8.00% in HC, PD, iRBD and PD+RBD respectively. The proposed interactive micro and macro sleep staging algorithm can be used in clinics to reduce the burden of manual sleep staging in elderly and patients with NDD.
- 1 July 2019
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- Vol. 2019, 3649-3652
A Clinically Applicable Interactive Micro and Macro-Sleep Staging Algorithm for Elderly and Patients with Neurodegeneration
Elderly and patients with neurodegenerative diseases (NDD) often complain about sleep problems and show altered sleep structure. Automated algorithms for efficient and specific sleep staging are needed. We propose a new algorithm using only one electroencephalographic and two electrooculographic channels to score wakefulness, rapid eye movement (REM) sleep and non-REM sleep in a cohort of elderly healthy controls (HC), patients with Parkinson’s disease (PD), isolated REM sleep behavior disorder (iRBD), considered the prodromal stage of PD, and patients with PD and RBD (PD+RBD). The proposed method scores both standard 30-s epochs (macro-staging) and 5-s mini-epochs (micro-staging), whose evaluation may help to better understand sleep micro-structure. Moreover, the algorithm is interactive, as it labels the classified sleep epochs as either certain or uncertain, so that experts can manually review the uncertain ones. The algorithm performances were evaluated for macro-sleep staging, where it achieved overall accuracies of 0.87±0.05 in 41 HC, 0.86±0.10 in 57 PD, 0.76±0.10 in 31 iRBD and 0.77±0.10 in 30 PD+RBD patients when all 30-s epochs were considered. The accuracies increased to 0.91±0.05, 0.90±0.08, 0.85±0.09, 0.88±0.08 respectively when considering only the certain ones. The epochs labeled as uncertain were 9.95±4.15%, 11.13±7.86%, 18.39±7.38% and 18.90±8.00% in HC, PD, iRBD and PD+RBD respectively. The proposed interactive micro and macro sleep staging algorithm can be used in clinics to reduce the burden of manual sleep staging in elderly and patients with NDD.